2019 annual financial data

Stoke Therapeutics 2019 Operating margin

Stoke Therapeutics 2019 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -35,678,000 USD and net income was -28,524,000 USD.
Operating cash flow was -31,055,000 USD.

Get free Stoke Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-35,678,000 USD
Net income
-28,524,000 USD
Operating cash flow
-31,055,000 USD